SCHEMBL8776424

SCHEMBL8776424

CC(=O)C(C)=CC=CC=CC=CC1=C(C)C(=O)CCC1(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.61
ALOX15 P16050 3/20 0.61
ALDH1A1 P00352 10/20 0.35
PTGS1 P23219 4/20 0.35
LMNA P02545 2/20 0.35
DRD3 P35462 2/20 0.35
SLCO1B3 Q9NPD5 2/20 0.35
SLCO1B1 Q9Y6L6 2/20 0.35
RXRA P19793 5/20 0.34
CYP3A4 P08684 5/20 0.34
RARA P10276 4/20 0.34
RARB P10826 4/20 0.34
RARG P13631 4/20 0.34
APP P05067 3/20 0.34
SNCA P37840 3/20 0.34
RXRB P28702 2/20 0.34
RXRG P48443 2/20 0.34
RORC P51449 2/20 0.34
ADORA3 P0DMS8 2/20 0.34
MAPK1 P28482 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11417197 0.86 MAPT (0.85) MAPTALOX15ALDH1A1PTGS1LMNA
SCHEMBL11423435 0.85 MAPT (0.60) MAPTALOX15ALDH1A1PTGS1LMNA
SCHEMBL9840299 0.79 MAPT (0.51) MAPTALOX15ALDH1A1PTGS1LMNA
SCHEMBL9840296 0.79 MAPT (0.51) MAPTALOX15ALDH1A1PTGS1LMNA
SCHEMBL5437068 0.79 ALDH1A1 (0.58) MAPTALOX15ALDH1A1PTGS1LMNA
SCHEMBL8390312 0.76 MAPT (0.67) MAPTALOX15ALDH1A1PTGS1LMNA
SCHEMBL8390315 0.76 MAPT (0.67) MAPTALOX15ALDH1A1PTGS1LMNA
Canthaxanthin SCHEMBL12920083 0.76 MAPT (1.00) MAPTALOX15ALDH1A1PTGS1LMNA
Canthaxanthin SCHEMBL8971840 0.76 MAPT (1.00) MAPTALOX15ALDH1A1PTGS1LMNA
Canthaxanthin SCHEMBL19618 0.76 MAPT (1.00) MAPTALOX15ALDH1A1PTGS1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808159-A1 USE OR RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) WARNER-LAMBERT COMPANY (US) 1997-11-26 EP disclosed
WO-1996024344-A1 USE OF RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) WARNER-LAMBERT COMPANY (US) 1996-08-15 WO disclosed